• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2300278 比卡鲁胺片 bicalutamide Tablet Chemical Drugs License Renew 2023-06-29 view
JYHZ2300279 比卡鲁胺片 bicalutamide Tablet Chemical Drugs License Renew 2023-06-29 view
CYHS2201588 比卡鲁胺片 bicalutamide Tablet Chemical Drugs(4) Generic Drug 2022-09-22 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JYHZ2200172 比卡鲁胺片 bicalutamide Tablet Chemical Drugs License Renew 2022-07-02 view
JYHZ2200171 比卡鲁胺片 bicalutamide Tablet Chemical Drugs License Renew 2022-07-02 view
JYHB2200262 比卡鲁胺片 bicalutamide Tablet Chemical Drugs(5.2) Supplementary Application 2022-05-11 Sun Pharmaceutical Industries Ltd view
CYHB2150178 比卡鲁胺片 bicalutamide Tablet Chemical Drugs(原6) Supplementary Application 2021-03-26 上海复旦复华药业有限公司 Shanghai Fudan Forward Pharmaceutical Co Ltd In Review 2021-03-25 view
JYHB2100081 比卡鲁胺片 bicalutamide Tablet Chemical Drugs(5.2) Supplementary Application 2021-01-21 盛发药业(上海)有限公司 Sun Pharma (Shanghai) Co Ltd Filed 2021-01-28 view
CYHS2000906 比卡鲁胺片 bicalutamide Tablet Chemical Drugs(4) Generic Drug 2020-12-21 扬子江药业集团有限公司 Yangtze River Pharmaceutical (Group) Co Ltd In Review 2020-12-18 view
JYHB2002176 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2020-10-29 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Filed 2020-11-12 view
JYHB2002177 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2020-10-29 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Filed 2020-11-12 view
JYHB2001357 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2020-08-21 中文名称:阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-09-09 view
JYHB2001356 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2020-08-21 中文名称:阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-09-09 view
CYHB2050327 比卡鲁胺胶囊 bicalutamide Capsule Chemical Drugs Supplementary Application 2020-06-13 山西振东制药股份有限公司 Shanxi Zhendong Pharmaceutical Co Ltd In Review 2020-06-12 view
CYHB2050263 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2020-05-18 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2021-03-10 view
JYHB2040001 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2020-02-15 费森尤斯卡比(中国)投资有限公司 Fresenius Kabi (China) Company Limited Certificate Issued 2021-01-04 view
JYHF1900118 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2019-08-16 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-09-09 view
JYHF1900119 比卡鲁胺片 bicalutamide Tablet Chemical Drugs Supplementary Application 2019-08-16 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-09-11 view
JYHZ1900073 比卡鲁胺片 bicalutamide Tablet Chemical Drugs License Renew 2019-03-28 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-06-20 view
JYHZ1900072 比卡鲁胺片 bicalutamide Tablet Chemical Drugs License Renew 2019-03-18 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-06-20 view